Medication info

Nephsol Injection

Prescription medicationInjectionsInjection
Ingredient · strength
L-Isoleucine›0.56g / 100mLL-Leucine›0.88g / 100mLL-Lysine Acetate›0.9g / 100mLL-Methionine›0.88g / 100mLL-Phenylalanine›0.88g / 100mLL-Threonine›0.4g / 100mLL-Tryptophan›0.2g / 100mLL-Valine›0.64g / 100mLL-Histidine›0.25g / 100mL
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid contained in a colorless transparent polypropylene aqueous injection container.
Packaging
250 mL
Approval status
Active

MFDS item code 201310616 · Notified 2013.12.10 · Insurance code 640006501

Summary

Main use
Prevention of amino acid deficiency in acute and chronic renal failure
Who receives it
Adults · Children
Adult administration
○ Adults: Generally, 250∼500 mL per day (1.6∼3.2 g as nitrogen, 13.4∼26.8 g as essential amino acids) is administered by intravenous drip infusion. When a calorie source is administered at the same time, aseptically mix 250 mL of this drug with 500 mL of 70% glucose and use (diluted to 1.8% this drug and 47% glucose). ○ Administration rate: Usually, start at 20∼30 mL per hour and increase the rate by 10 mL per hour every 24 hours until a maximum of 60∼100 mL per hour is reached.
Child administration
○ Children: The initial total daily dose should be low and increased gradually. The dose must be kept below 1 g of essential amino acids per kg of body weight per day.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Prevention of amino acid deficiency in acute and chronic renal failure

View approved original text

This medication is used to supplement the amino acids necessary for patients with acute and chronic renal failure to improve their nutritional status.

How it is given

Adult administration

○ Adults: Generally, 250∼500 mL per day (1.6∼3.2 g as nitrogen, 13.4∼26.8 g as essential amino acids) is administered by intravenous drip infusion. When a calorie source is administered at the same time, aseptically mix 250 mL of this drug with 500 mL of 70% glucose and use (diluted to 1.8% this drug and 47% glucose). ○ Administration rate: Usually, start at 20∼30 mL per hour and increase the rate by 10 mL per hour every 24 hours until a maximum of 60∼100 mL per hour is reached.

Child administration

○ Children: The initial total daily dose should be low and increased gradually. The dose must be kept below 1 g of essential amino acids per kg of body weight per day.

Precautions

This medicine should be used only as directed by a physician. It should not be administered to patients with hepatic dysfunction such as hepatic coma, severe electrolyte and acid-base imbalances, reduced blood circulation, hyperammonemia, and those with congenital amino acid metabolism disorders. Caution should be exercised in patients with congestive heart failure, children, underweight patients, patients relying heavily on nitrogen sources, patients with gastrointestinal bleeding or at risk of hyperammonemia. Additionally, this medication contains sodium bisulfite, which may cause allergic reactions or asthma attacks in some patients, so care should be taken. During administration, side effects such as itching, rash, nausea, vomiting, and palpitations may occur. Rapid administration in large volumes may cause acidosis. Liver function tests may show elevated levels, and changes in blood urea nitrogen and ammonia levels may occur, with an increased risk of thrombophlebitis. Particularly in patients with severe gastrointestinal bleeding or in children, hyperammonemia may occur, requiring caution. This medication is used for acute patients requiring strict low-protein diets, dialysis patients, and those unable to take oral medication. During administration, blood fluid, electrolyte, and acid-base status, as well as BUN levels, must be monitored regularly, and diabetic patients should control their blood sugar levels. If only amino acid solution is administered, ketones may accumulate, so it is advisable to administer it with carbohydrates. This medication may generate toxic substances when mixed with other drugs, so only drugs confirmed for compatibility should be mixed carefully, and the mixture should be used immediately after preparation. Overdosage may lead to side effects or edema, so administration should be stopped or the dosage reduced for slow administration. Care should be taken for electrolyte balance during administration, and it should be infused slowly intravenously; rapid infusion may cause chills or vomiting. This medication should always be prepared in a sterile condition and must be stored properly to prevent deterioration, with any remaining solution not to be reused.

Side effects

Generalized pruritus, rash, generalized urticaria, nausea, vomiting, loss of appetite, chest discomfort, palpitations, acidosis, increased AST/ALT, elevated BUN, chills, fever,热感, head burning sensation, headache, vascular pain, thrombotic venous inflammation, hyperammonemia, delayed response to naming or stimuli, reduced or lost voluntary movements and speech, decreased calculation ability, cognitive impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, and it is safest to store it at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid contained in a colorless transparent polypropylene aqueous injection container.

Package unit

250 mL

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.